Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer.
Kawaida H, Kono H, Amemiya H, Saitou R, Yamamoto A, Hosomura N, Watanabe M, Kimura A, Furuya S, Shimizu H, Akaike H, Kawaguchi Y, Sudo M, Itakura J, Hayakawa H, Shindo H, Takahashi EI, Takano S, Fukasawa M, Ichikawa S, Fujii H, Ichikawa D.
Kawaida H, et al. Among authors: ichikawa d, ichikawa s.
Anticancer Res. 2018 Nov;38(11):6537-6542. doi: 10.21873/anticanres.13019.
Anticancer Res. 2018.
PMID: 30396983